The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms
NCT04844710 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2021-04-14
Summary
Coronavirus disease 2019 (COVID-19) is a problem that is being faced in more than 200 countries in the world, including Indonesia. The World Health Organization (WHO) has declared the COVID-19 outbreak as a pandemic. The transmission of the virus occurred rapidly that 2 weeks from the first case diagnosed, 1000 patients tested positive. A week later, the number of positive cases exceeded 4600, reaching more than 30,000 patients and 2,500 deaths on March 18, 2020. The death rate due to COVID-19 in Indonesia is one of the highest in Asia.
To date, no therapy has been shown to be effective for Coronavirus (SARS-CoV-2). A vaccine for SARS-CoV-2 also has not been found at this time and is in the research phase. Current management of COVID-19 patients focuses primarily on providing supportive care. Currently, several countries make treatment guidelines for COVID-19 patients by providing several types of anti-viral drugs and other drugs such as chloroquine or hydroxychloroquine, immunoglobulins, anti-cytokine agents or immunomodulators.
The administration of these drugs does not escape the various side effects experienced by patients. Administration of chloroquine or hydroxychloroquine carries the risk of causing prolonged QT interval which can lead to arrhytmia disturbances such as torsades des pointes in certain people. Administration of chloroquine or hydroxychloroquine in combination with azithromycin increases the risk of developing arrhythmias. Giving anti-viruses such as lopinavir / ritonavir, umifenovir, remdesivir, favipiravir can also cause various side effects including gastrointestinal disturbances (nausea, vomiting, diarrhea), impaired liver function, and hyperuricaemia. Treatment with human immunoglobulins has been associated with a significantly increased risk of thrombotic events.
Currently, no acupuncture research on COVID-19 patients has been published. However, acupuncture can play a role in several conditions that occur in COVID-19 according to the pathophysiology that occurs, this has been proven through several clinical studies conducted on non-COVID-19 cases that have pathophysiology that resemble COVID-19 conditions. In COVID-19 with mild-moderate symptoms, acupuncture can play a role in boosting the immune system, including increasing the number of Natural Killer cells and lymphocytes. Whereas in cases of severe COVID-19 symptoms, it is hoped that acupuncture can provide anti-inflammatory effect and prevent cytokine storm.
Conditions
- Acupuncture
- Covid19
Interventions
- COMBINATION_PRODUCT
-
acupuncture and standard care
manual acupuncture in acupoint LI4, LI11, ST36 every 2 days for 6 times standard care
- DRUG
-
standard care
standard care only
Sponsors & Collaborators
-
Indonesia University
lead OTHER
Principal Investigators
-
Dwi Rachma Helianthi, MD · Indonesia University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2020-11-15
- Completion
- 2020-11-20
Countries
- Indonesia
Study Locations
More Related Trials
-
Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus
NCT04323345 ·Status: UNKNOWN ·Phase: PHASE3
-
Complementary Self-help Strategies for Patients With Post-COVID-19 Syndrome
NCT05798221 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19
NCT04291053 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection
NCT04251871 ·Status: UNKNOWN ·Phase: NA
-
Acupuncture and Moxibustion for Hyperlipemia
NCT02269046 ·Status: UNKNOWN ·Phase: NA
-
Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19
NCT04653727 ·Status: COMPLETED
-
Traditional Chinese Medicine for Severe COVID-19
NCT04323332 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection
NCT05672498 ·Status: UNKNOWN ·Phase: NA
-
Randomized Controlled Trial of Acupuncture for Dysmenorrhea
NCT01116453 ·Status: COMPLETED ·Phase: PHASE3
-
TCM Differentiation and Treatment Protocol of COVID-19
NCT04306497 ·Status: COMPLETED
-
Impact Nerium Oleander on Immune Function
NCT04486144 ·Status: COMPLETED ·Phase: NA
-
Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention
NCT04388644 ·Status: UNKNOWN
-
Efficacy and Immunomodulator Impact of Herbal Combination on COVID-19 Patients Recovery
NCT06636760 ·Status: COMPLETED ·Phase: NA
-
Effect of Acupuncture on Patients With Mild Hypertension
NCT01701726 ·Status: COMPLETED ·Phase: PHASE3
-
Cupping Therapy on Immune System in Post Covid -19
NCT05901337 ·Status: COMPLETED ·Phase: NA
-
Acupuncture and Chinese Herbal Medicine to Improve Live Birth Rate of in Vitro Fertilization (IVFAct)
NCT04407871 ·Status: UNKNOWN ·Phase: NA
-
Acute Health Effects of High Temperature Exposure
NCT05575752 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Psychological Outcomes From a Study of Acupuncture Treatment on Experimentally Primary Dysmenorrhea
NCT00689897 ·Status: UNKNOWN ·Phase: PHASE3
-
Pilot Trial of XFBD, a TCM, in Persons With COVID-19
NCT04810689 ·Status: TERMINATED ·Phase: PHASE2
-
Traditional Chinese Medicine for Complications in Critically Ill Patients
NCT05458687 ·Status: UNKNOWN ·Phase: NA
-
Complementary and Integrative Medicine as an Online Intervention in Patients With Post-covid Syndrome After COVID-19
NCT06004362 ·Status: RECRUITING ·Phase: NA
-
A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection
NCT02539277 ·Status: UNKNOWN ·Phase: PHASE4
-
RCT of Modified Qing Fei Pai Du Tang (mQFPD) for COVID-19
NCT04939415 ·Status: COMPLETED ·Phase: PHASE1
-
Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents
NCT04668222 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Manual Acupuncture (MA) for Asymptomatic Hyperuricemia (HUA)
NCT06824376 ·Status: RECRUITING ·Phase: NA